Syka Laboratories (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.90 M
- Company Age 25 Year, 8 Months
- Last Filing with ROC 31 Mar 2008
- Open Charges ₹ 0.80 M
About Syka Laboratories (India)
Syka Laboratories (India) Private Limited (SLIPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 May 1999 and has a history of 25 years and eight months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2008. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.90 M.
The company currently has active open charges totaling ₹0.80 M.
Prabhas Singh and Kalyani Singh serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230GJ1999PTC035931
-
Company No.
035931
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 May 1999
-
Date of AGM
29 Sep 2008
-
Date of Balance Sheet
31 Mar 2008
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Syka Laboratories (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prabhas Singh
|
Director | 05-May-1999 | Current |
|
Kalyani Singh
|
Director | 05-May-1999 | Current |
Financial Performance of Syka Laboratories (India).
Enhance accessibility to Syka Laboratories (India)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Syka Laboratories (India)?
Unlock access to Syka Laboratories (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0.80 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 0.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Apr 2006 | Canara Bank | ₹0.80 M | Open |
How Many Employees Work at Syka Laboratories (India)?
Unlock and access historical data on people associated with Syka Laboratories (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Syka Laboratories (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Syka Laboratories (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.